Fibronostics
Manufacturing · Louisiana, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
615 Baronne St Ste 100, New Orleans, Lou...Phone Number
(888) 552-1603Website
www.fibronostics.comRevenue
$10.8 MillionIndustry
About Fibronostics
Fibronostics Org Chart
Is Fibronostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Fibronostics has new funding data
Check if Fibronostics has recently received funding, and reach out quickly before it becomes old news!
Check out if Fibronostics is spiking on competitors!
Earning: See what the market has to say on Fibronostics recently announced quarterly report
Fibronostics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Fibronostics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Fibronostics
Product Launch: Get notified when Fibronostics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Fibronostics as Masked Content
Find more new buyers
Compare Similar Companies to Fibronostics
Compare insights from companies similar to Fibronostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fibronostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Fibronostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Fibronostics.
Fibronostics financials insights
Gather financial insights about Fibronostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$8M
Unspecified
$6.5M
Fibronostics Tech Stack
A closer look at the technologies used by Fibronostics
Most Recent Scoops
Fibronostics News & Media
Fibronostics Announces Partnership with Stone Diagnostics
SANTA ROSA BEACH, Fla. and SINGAPORE, Oct. 10, 2023 /PRNewswire/ -- Fibronostics, a global leader in non-invasive, AI-driven diagnostic testing for *MAFLD/MASH patients, announced today a strategic partnership with Stone Diagnostics, a leading provider of laboratory services in the United...Fibronostics Secures Financing, Announces New CEO
NEW YORK and SINGAPORE, June 15, 2022 /PRNewswire/ -- Fibronostics, a global leader in non-invasive, AI-driven diagnostics for NASH patients, announced today it has secured $6.5 million in funding. In addition to the financing, Sven Henrichwark, PhD, has been named the company's CEO....Fibronostics and Fatty Liver Foundation Announce a Patient Education Partnership
ORLANDO, Fla. and BOISE, Idaho, Dec. 7, 2020 /PRNewswire/ -- Fibronostics and the Fatty Liver Foundation are pleased to announce they have entered into a strategic collaboration, combining Fibronostics' industry leading in vitro diagnostics platform for metabolic conditions with the Fatty...Fibronostics Raises $8 Million in Series A Financing
NEW YORK and SINGAPORE, Aug. 24, 2020 /PRNewswire/ -- Fibronostics, a global company providing non-invasive, algorithmic diagnostics for NASH patients, announced today that it has secured $8 million in series A funding. The financing round was led by AT Capital, a leading private...
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fibronostics
Fibronostics is a global diagnostics company, shaping the future of non-invasive diagnostics with artificial intelligence providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on screening, progression and prognosis of liver & kidney disease, and other chronic conditions. The company is incorporated in Singapore & N... Read More